These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Diagnosis
35 results:

  • 1. Clinicopathological and Molecular Features of Penile Melanoma With a Proposed Staging System.
    Cornejo KM; Goyal A; Valencia Guerrero A; Astudillo M; Dias-Santagata D; Johnson MM; Feldman AS; Hoang MP
    Am J Surg Pathol; 2024 Jul; 48(7):825-833. PubMed ID: 38808927
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family.
    Abdelmaksoud-Dammak R; Ammous-Boukhris N; BenAyed-Guerfali D; Gdoura Y; Boujelben I; Guidara S; Charfi S; Boudabbous W; Ammar S; Rhaiem W; Boudawara MZ; Kamoun H; Sallemi-Boudawara T; Mhiri R; Mokdad-Gargouri R
    Fam Cancer; 2024 Nov; 23(4):515-522. PubMed ID: 38687438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
    Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
    Zhang H; Jiang D; Meng E; Zhao M; Niu B
    Immunotherapy; 2023 Jan; 15(1):17-25. PubMed ID: 36647794
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cerebral developmental venous anomalies in children with mismatch repair deficiency.
    Kara B; Paksoy Y; Çağlayan AO; Seher N; Akbaş H; Köksal Y
    Turk J Pediatr; 2022; 64(6):1106-1116. PubMed ID: 36583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and msh6 expression: a case report.
    Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N
    Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrating tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.
    Dixon K; Asrat MJ; Bedard AC; Binnington K; Compton K; Cremin C; Heidary N; Lohn Z; Lovick N; McCullum M; Mindlin A; O'Loughlin M; Petersen T; Portigal-Todd C; Scott J; St-Martin G; Thompson J; Turnbull R; Mung SW; Hong Q; Bezeau M; Bosdet I; Tucker T; Young S; Yip S; Aubertin G; Blood KA; Nuk J; Sun S; Schrader KA
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00397. PubMed ID: 34397043
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas - institutional experience and review of literature.
    Alphones S; Chatterjee U; Singh A; Das A; Zameer L; Achari R; Bhattacharya A; Roy P
    Childs Nerv Syst; 2021 Aug; 37(8):2521-2530. PubMed ID: 34097097
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Constitutional mismatch repair deficiency (CMMRD) presenting with high-grade glioma, multiple developmental venous anomalies and malformations of cortical development-a multidisciplinary/multicentre approach and neuroimaging clues to clinching the diagnosis.
    Chhabda S; Sudhakar S; Mankad K; Jorgensen M; Carceller F; Jacques TS; Merve A; Aizpurua M; Chalker J; Garimberti E; D'Arco F
    Childs Nerv Syst; 2021 Jul; 37(7):2375-2379. PubMed ID: 33247381
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
    Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
    Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).
    Lou L; Lv F; Wu X; Li Y; Zhang X
    Eur J Surg Oncol; 2021 Feb; 47(2):323-330. PubMed ID: 32907775
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.
    Kientz C; Prieur F; Clemenson A; Joly MO; Stachowicz ML; Auclair J; Attignon V; Schiappa R; Wang Q
    Fam Cancer; 2020 Jan; 19(1):11-14. PubMed ID: 31745674
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.
    Yang C; Austin F; Richard H; Idowu M; Williamson V; Sabato F; Ferreira-Gonzalez A; Turner SA
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604779
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Malignant phyllodes tumor in Lynch syndrome: a case report.
    Kazmi S; Wagner S; Heintzelman R; Corbman M
    J Med Case Rep; 2019 Jul; 13(1):216. PubMed ID: 31307558
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma.
    Indraccolo S; Lombardi G; Fassan M; Pasqualini L; Giunco S; Marcato R; Gasparini A; Candiotto C; Nalio S; Fiduccia P; Fanelli GN; Pambuku A; Della Puppa A; D'Avella D; Bonaldi L; Gardiman MP; Bertorelle R; De Rossi A; Zagonel V
    Clin Cancer Res; 2019 Mar; 25(6):1828-1837. PubMed ID: 30514778
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel infram deletion in msh6 gene in glioma: Conversation on msh6 mutations in brain tumors.
    Deris Zayeri Z; Tahmasebi Birgani M; Mohammadi Asl J; Kashipazha D; Hajjari M
    J Cell Physiol; 2019 Jul; 234(7):11092-11102. PubMed ID: 30478893
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
    AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
    Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.